Risk of breast, ovary, and uterine corpus cancers among 85 268 women with AIDS

British Journal of Cancer

Volumn 95, Issue 5, 2006, Pages 642-648

  Goedert, J J ^a   Schairer, C ^a   McNeel, T S ^b   Hessol, N A ^c   Rabkin, C S ^a   Engels, E A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Breast cancer; Endometrial cancer; Human immunodeficiency virus (HIV); Ovarian cancer; Risk factors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; UTERUS CANCER;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; BREAST NEOPLASMS; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; MENOPAUSE; MIDDLE AGED; OVARIAN NEOPLASMS; POISSON DISTRIBUTION; REGISTRIES; RISK; UNITED STATES; UTERINE NEOPLASMS;

EID: 33748310615     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603282     Document Type: Article

References (53)

1. Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA (2003) Breast cancers among very young premenopausal women (United States). Cancer Causes Control 14: 151-160
2. Amir H, Kaaya EE, Kwesigabo G, Kiitinya JN (2000) Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry data 1968 to 1996. J Natl Med Assoc 92: 301-305
3. Asin SN, Wildt-Perinic D, Mason SI, Howell AL, Wira CR, Fanger MW (2003) Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity. J Infect Dis 187: 1522-1533
4. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA (2005) The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 12: 1013-1019
5. Ballard-Barbash R, Swanson CA (1996) Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 63: 437S-441S
6. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J (1998) The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9: 117-125
7. Beral V, Newton R (1998) Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr 23: 1-6
8. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK (1994) Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 86: 1403-1408
9. Bettaccini AA, Baj A, Accolla RS, Basolo F, Toniolo AQ (2005) Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes. BMC Microbiol 5: 20
10. Borges HT, Watkins J, Stafford R, Biggar RJ (2001) Linkage of selected AIDS and cancer registries in the United States. J Registry Manage 28: 89-92
11. Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ 82: 1-406
12. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN (1992) Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167: 1317-1325
13. Centers for Disease Control and Prevention (2002) 2000 National Health Interview Survey (NHIS) public use data release: NHIS survey description. US Department of Health and Human Services: Hyattsville, MD
14. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC (2005) Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. AIDS 19: 1415-1422
15. Cote TR, Biggar RJ, Rosenberg PS, Devesa SS, Percy C, Yellin FJ, Lemp G, Hardy C, Goedert JJ, Blattner WA (1997) Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73: 645-650
16. Ellerbrock TV, Wright TC, Bush TJ, Dole P, Brudney K, Chiasson MA (1996) Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet Gynecol 87: 1030-1034
17. Engels EA, Frisch M, Biggar RJ, Goedert JJ (2003) Re: 'Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus'. Am J Epidemiol 157: 955-956
18. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288: 1723-1727
19. Forsyth BW, Davis JA, Freudigman KA, Katz KH, Zelterman D (2002) Pregnancy and birth rates among HIV-infected women in the United States: the confounding effects of illicit drug use. AIDS 16: 471-479
20. Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, Falcini F, Zanetti R, Barchielli A, Serraino D, Rezza G (1998) Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 78: 966-970
21. Friedenreich CM (2001) Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10: 15-32
22. Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736-1745
23. Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92: 1500-1510
24. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International classification of diseases for oncology 3rd edn World Health Organization: Geneva
25. Goedert JJ (2000) The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27: 390-401
26. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833-1839
27. Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A (1997) Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 82: 1332-1337
28. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM (2002) Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16: 1155-1161
29. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM (1999) Risk of cancer in people with AIDS. AIDS 13: 839-843
30. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21: 3447-3453
31. Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia O, Levine AM (2004) Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr 36: 978-985
32. Howell AL, Edkins RD, Rier SE, Yeaman GR, Stern JE, Fanger MW, Wira CR (1997) Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J Virol 71: 3498-3506
33. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94: 606-616
34. Lee LM, Wortley PM, Fleming PL, Eldred LJ, Gray RH (2000) Duration of human immunodeficiency virus infection and likelihood of giving birth in a Medicaid population in Maryland. Am J Epidemiol 151: 1020-1028
35. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43: 209-221
36. Michels KB, Ekbom A (2004) Caloric restriction and incidence of breast cancer. JAMA 291: 1226-1230
37. Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S (1998) Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 83: 2717-2725
38. Mulligan K, Anastos K, Justman J, Freeman R, Wichienkuer P, Robison E, Hessol NA (2005) Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 38: 18-22
39. Nawar E, Mbulaiteye S, Gallant JE, Wohl DA, Ardini M, Hendershot T, Goedert JJ, Rabkin C (2005) Risk Factors for Kaposi's Sarcoma among HHV-8 Seropositive Homosexual Men with AIDS. Int J Cancer 115: 296-300
40. Phillips DM, Bourinbaiar AS (1992) Mechanism of HIV spread from lymphocytes to epithelia. Virology 186: 261-273
41. Preston-Martin S, Kirstein LM, Pogoda JM, Rimer B, Melnick S, Masri-Lavine L, Silver S, Hessol N, French AL, Feldman J, Sacks HS, Deely M, Levine AM (2002) Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS). Prev Med 34: 386-392
42. Ries L, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L (2005) SEER Cancer Statistics Review, 1975-2002. National Cancer Institute: Bethesda, MD
43. Rose DP, Komninou D, Stephenson GD (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5: 153-165
44. Shuter J, Chang CJ, Klein RS (2001) Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr 26: 291-297
45. Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, Fernandez-DiFranco MG, Knox TA (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 12: 1645-1651
46. Southern SO (1998) Milk-borne transmission of HIV. Characterization of productively infected cells in breast milk and interactions between milk and saliva.. J Hum Virol 1: 328-337
47. Steenland K, Greenland S (2004) Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol 160: 384-392
48. Sturgeon SR, Potischman N, Malone KE, Dorgan JF, Daling J, Schairer C, Brinton LA (2004) Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Cancer Causes Control 15: 45-53
49. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A (1995) Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9: 859-866
50. Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE (2005) Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer 114: 996-1001
51. Wyshak G, Frisch RE (2000) Breast cancer among former college athletes compared to non-athletes: a 15-year follow-up. Br J Cancer 82: 726-730
52. Yeaman GR, Howell AL, Weldon S, Demian DJ, Collins JE, O'Connell DM, Asin SN, Wira CR, Fanger MW (2003) Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 109: 137-146
53. Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L (2005) Body mass index and breast cancer risk in African American women. Ann Epidemiol 15: 123-128